Patient-Derived Explants as a Precision Medicine Patient-Proximal Testing Platform Informing Cancer Management

Precision medicine approaches that inform clinical management of individuals with cancer are progressively advancing. Patient-derived explants (PDEs) provide a patient-proximal ex vivo platform that can be used to assess sensitivity to standard of care (SOC) therapies and novel agents. PDEs have sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Templeton, Abby R., Jeffery, Penny L., Thomas, Patrick B., Perera, Mahasha P. J., Ng, Gary, Calabrese, Alivia R., Nicholls, Clarissa, Mackenzie, Nathan J., Wood, Jack, Bray, Laura J., Vela, Ian, Thompson, Erik W., Williams, Elizabeth D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721047/
https://www.ncbi.nlm.nih.gov/pubmed/34988013
http://dx.doi.org/10.3389/fonc.2021.767697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721047/
https://www.ncbi.nlm.nih.gov/pubmed/34988013
http://dx.doi.org/10.3389/fonc.2021.767697

Ejemplares similares